Lindbrook Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $10.3K | Buy |
1,446
+1,383
| +2,195% | +$9.83K | ﹤0.01% | 1639 |
|
|
2024
Q4 | $735 | Sell |
63
-24
| -28% | -$280 | ﹤0.01% | 2534 |
|
|
2024
Q3 | $1.79K | Sell |
87
-176
| -67% | -$3.62K | ﹤0.01% | 2384 |
|
|
2024
Q2 | $5.89K | Sell |
263
-283
| -52% | -$6.33K | ﹤0.01% | 1916 |
|
|
2024
Q1 | $15K | Sell |
546
-59
| -10% | -$1.62K | ﹤0.01% | 1363 |
|
|
2023
Q4 | $18.4K | Buy |
605
+380
| +169% | +$11.6K | ﹤0.01% | 1219 |
|
|
2023
Q3 | $7.12K | Buy |
225
+48
| +27% | +$1.52K | ﹤0.01% | 1586 |
|
|
2023
Q2 | $7.22K | Buy |
177
+92
| +108% | +$3.75K | ﹤0.01% | 1636 |
|
|
2023
Q1 | $3.17K | Sell |
85
-31
| -27% | -$1.16K | ﹤0.01% | 2048 |
|
|
2022
Q4 | $4.05K | Sell |
116
-123
| -51% | -$4.29K | ﹤0.01% | 1928 |
|
|
2022
Q3 | $13K | Buy |
239
+21
| +10% | +$1.14K | ﹤0.01% | 1205 |
|
|
2022
Q2 | $11K | Sell |
218
-12
| -5% | -$606 | ﹤0.01% | 1223 |
|
|
2022
Q1 | $17K | Sell |
230
-370
| -62% | -$27.3K | ﹤0.01% | 1077 |
|
|
2021
Q4 | $71K | Buy |
600
+552
| +1,150% | +$65.3K | 0.01% | 605 |
|
|
2021
Q3 | $6K | Hold |
48
| – | – | ﹤0.01% | 1202 |
|
|
2021
Q2 | $8K | Sell |
48
-97
| -67% | -$16.2K | ﹤0.01% | 1144 |
|
|
2021
Q1 | $12K | Buy |
+145
| New | +$12K | ﹤0.01% | 944 |
|
|
2020
Q3 | – | Sell |
-187
| Closed | -$4K | – | 1818 |
|
|
2020
Q2 | $4K | Buy |
+187
| New | +$4K | ﹤0.01% | 1186 |
|